Therapeutic implications of gender differences in supraventricular cardiac arrhythmias: lessons of life cannot be learned in a day

References

• Seow S-C, Lim T-W, Koay C-H, Ross DL, Thomas SP. Efficacy and late recurrences with wide electrical pulmonary vein isolation for persistent and permanent atrial fibrillation. Europace9, 1129–1133 (2007).
   PubMed Web of Science ®Google Scholar
• Forleo GB, Tondo C, De Luca L et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace9, 613–620 (2007).
   PubMed Web of Science ®Google Scholar
• Deneke T, Müller P, Lawo T et al. Gender differences in onset of symptoms in AV nodal re-entrant and accessory pathway-mediated re-entrant tachycardia. Herzschr. Elektrophysiol.20, 33–38 (2009).
   PubMedGoogle Scholar
• Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J. Am. Coll. Cardiol.42, 1103–1107 (2003).
   PubMed Web of Science ®Google Scholar
• Schulze-Bahr E, Kirchhoff P. Eckardt L, Bertrand J, Breithardt G. Gender differences in cardiac arrhythmia. Herz30, 390–400 (2005).
   PubMed Web of Science ®Google Scholar
• Bernal O, Moro C. Cardiac arrhythmia in women. Rev. Esp. Cardiol.59, 609–618 (2006).
   PubMed Web of Science ®Google Scholar
• Bazett HC. An analysis of the time-relations of electrocardiograms. Heart7, 353–370 (1920).
   Google Scholar
• Liu S, Yuan S, Hertervig E et al. Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff–Parkinson–White syndrome. J. Electrocardiol.34, 295–301 (2001).
   PubMed Web of Science ®Google Scholar
• Liuba I, Jönsson A, Säfström K, Walfridsson H. Gender related differences in patients with atrioventricular nodal reentry tachycardia. Am. J. Cardiol.97, 1645–1649 (2006).
   Google Scholar
• Rubart M, von der Lohe E. Sex steroids and cardiac arrhythmia: more questions than answers. J. Cardiovasc. Electrophysiol.9, 665–667 (1998).
   PubMed Web of Science ®Google Scholar
• Nakamura H, Kurokamwa J, Bai C-X et al. Progesterone regulates cardiac repolarization through a nongenomic pathway. Circulation116, 2913–2922 (2007).
   PubMed Web of Science ®Google Scholar
• Kibos A, Deharo JC, Adoubi A et al. Clinical and electrophysiological study of asymptomatic Wolff–Parkinson–White syndrome. Ann. Cardiol. Angiol.56, 237–240 (2007).
   PubMedGoogle Scholar
• Pham TV, Sosunov EA, Anyukhovsky EP, Danilo P, Rosen MR. Testosterone diminishes the proarrhythmic effects of dofetilide in normal female rabbits. Circulation106, 2132–2136 (2002).
   PubMed Web of Science ®Google Scholar
• Pappone C, Santinelli V, Manguso F et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff–Parkinson–White Syndrome. N. Engl. J. Med.349, 1803–1811 (2003).
   PubMed Web of Science ®Google Scholar
• Calkins H, Yong P, Miller JM et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction. Circulation99, 262–270 (1999).
   PubMed Web of Science ®Google Scholar
• Liu S, Olsson SB, Hertervig E, Kongstad O, Yuan S. Atrioventricular conduction: a determinant for the manifestation of ventricular preexcitation in patients with Wolff–Parkinson–White syndrome. Clin. Physiol.21, 534–540 (2008).
   Google Scholar
• Watson RE, Stein AD, Dwamena FC et al. Do race and gender influence the use of invasive procedures? J. Gen. Intern. Med.16, 227–234 (2001).
   PubMed Web of Science ®Google Scholar
• Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm2, 1277–1282 (2005).
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, d’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation98(10), 946–952 (1998).
   PubMed Web of Science ®Google Scholar
• Wachtell K, Lehto M, Gerdts E et al. Angiosentin II receptor blockade reduces new-onset arial fibrillation and subsequent stroke compared to atenolol: the Lorsartan Intervention For End Point Reduction in Hypertension (LIFE) study. J. Am. Coll. Cardiol.45, 712–719 (2005).
   PubMed Web of Science ®Google Scholar
• Jankowski M, Rachelska G, Donghao W, McCann SM, Gutkowska J. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc. Natl Acad. Sci. USA98, 11765–11770 (2001).
   PubMed Web of Science ®Google Scholar
• Huikuri HV, Pikkujamsa SM, Airaksinen KEJ et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation94, 122–125 (1996).
   PubMed Web of Science ®Google Scholar
• Feinberger WM, Blackshear JL, Laupacis A, Kronmol R, Hart RG. Prevalence, age distribution and gender of patients with atrial fibrillation. Arch. Intern. Med.155, 469–473 (1995).
   PubMedGoogle Scholar
• Fang MC, Singer DE, Chang Y et al. Gender differences in the risk of ischemic stroke and peripheral emboli in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation112, 1687–1691 (2005).
   PubMed Web of Science ®Google Scholar
• Rosano GM, Panina G. Oestrogens and the heart. Therapie54, 381–385 (1999).
   PubMed Web of Science ®Google Scholar
• Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am. J. Cardiol.72, 838–840 (1993).
   PubMed Web of Science ®Google Scholar
• Lee SH, Chen SA, Wu TJ et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am. J. Cardiol.76, 675–678 (1995).
   PubMed Web of Science ®Google Scholar
• Rosano GMC, Leonardo F, Sorrel PM, Beale CM, DeLuca F, Collins P. Cyclic variation in paroxysmal supraventricular tachycardia in women. Lancet347, 786–788 (1996).
   PubMed Web of Science ®Google Scholar
• Myerburg RJ, Cox MM, Interian A et al. Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiology procedures. Am. J. Cardiol.83, 1049–1054 (1999).
   PubMed Web of Science ®Google Scholar
• Wolbrette D, Naccarelli G, Curtis A, Lehmann M, Dakish A. Gender differences in arrhythmias. Clin. Cardiol.25, 49–56 (2002).
   PubMed Web of Science ®Google Scholar
• Porter MJ, Morton JB, Denman R et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm4, 393–396 (2004).
   Google Scholar
• Hnatkova K, Walstare JEP, Urgatroyd FD. Age and gender influences on rate and duration of paroxysmal atrial fibrillation. Pacing Clin. Electrophysiol.21, 2455–2458 (1998).
   PubMed Web of Science ®Google Scholar
• Kenshalo DR. Changes in the cool threshold associated with phases of the menstrual cycle. J. Appl. Physiol.21, 1031–1039 (1966).
   PubMed Web of Science ®Google Scholar
• Lessmeier TJ, Gamperling D, Johnson-Liddon V et al. Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis of panic disorder. Arch. Intern. Med.157, 537–543 (1997).
   PubMedGoogle Scholar
• Calkins H, Brugada J, Packer DL et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace9, 335–379 (2007).
   PubMed Web of Science ®Google Scholar
• Earley MJ, Abrams DJR, Staniforth AD, Sporton SC, Schilling RJ. Catheter ablation of permanent atrial fibrillation: medium term results. Heart92, 233–238 (2006).
   PubMed Web of Science ®Google Scholar
• Oral H, Chugh Am, Good E et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation115, 2606–2612 (2007).
   PubMed Web of Science ®Google Scholar